{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:19:47Z","timestamp":1789517987279,"version":"build-2803163510"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herzschr Elektrophys"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00399-025-01121-6","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:46:10Z","timestamp":1762875970000},"page":"313-320","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A\u00a0review of the extravascular implantable cardioverter-defibrillator system: technology, development, clinical outcomes, and global experience","\u00dcbersicht zum extravaskul\u00e4ren implantierbaren Kardioverter-Defibrillator-System \u2013 Technik, Entwicklung, klinische Ergebnisse und globale Erfahrungen"],"prefix":"10.1007","volume":"36","author":[{"given":"Christopher","family":"Shepley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vibeke","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,11]]},"reference":[{"issue":"47","key":"1121_CR1","doi-asserted-by":"publisher","first-page":"4872","DOI":"10.1093\/eurheartj\/ehac496","volume":"43","author":"R Knops","year":"2022","unstructured":"Knops R et al (2022) Device-related complications in subcutaneous versus transvenous ICD: a secondary analysis of the PRAETORIAN trial. Eur Heart J 43(47):4872\u20134883. https:\/\/doi.org\/10.1093\/eurheartj\/ehac496","journal-title":"Eur Heart J"},{"key":"1121_CR2","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ijcard.2021.22.029","volume":"349","author":"N Nso","year":"2022","unstructured":"Nso N et al (2022) Comparative Assessment of Transvenous versus Subcutaneous Implantable Cardioverter-defibrillator Therapy Outcomes: An Updated Systematic Review and Meta-analysis. Int J Cardiol 349:62\u201378. https:\/\/doi.org\/10.1016\/j.ijcard.2021.22.029","journal-title":"Int J Cardiol"},{"issue":"3","key":"1121_CR3","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s10840-020-00929-1","volume":"60","author":"L Su","year":"2021","unstructured":"Su L, Guo J, Hao Y, Tan H (2021) Comparing the safety of subcutaneous versus transvenous ICDs: a meta-analysis. J Interv Card Electrophysiol 60(3):355\u2013363. https:\/\/doi.org\/10.1007\/s10840-020-00929-1","journal-title":"J Interv Card Electrophysiol"},{"key":"1121_CR4","doi-asserted-by":"publisher","first-page":"1397138","DOI":"10.3389\/fcvm.2024.1397138","volume":"11","author":"F Schiedat","year":"2024","unstructured":"Schiedat F et al (2024) Comparison of infection and complication rates associated with transvenous vs. subcutaneous defibrillators in patients with stage 4 chronic kidney disease: a multicenter long-term retrospective follow-up. Front Cardiovasc Med 11:1397138. https:\/\/doi.org\/10.3389\/fcvm.2024.1397138","journal-title":"Front Cardiovasc Med"},{"issue":"6","key":"1121_CR5","doi-asserted-by":"publisher","first-page":"498","DOI":"10.21470\/1678-9741-2017-0082","volume":"32","author":"FSO Souza","year":"2017","unstructured":"Souza FSO et al (2017) Subcutaneous Implantable Cardioverter Defibrillator: Early Experience. Braz J Cardiovasc Surg 32(6):498\u2013502. https:\/\/doi.org\/10.21470\/1678-9741-2017-0082","journal-title":"J Cardiovasc Surg"},{"key":"1121_CR6","doi-asserted-by":"publisher","first-page":"1008311","DOI":"10.3389\/fcvm.2022.1008311","volume":"9","author":"B Kattih","year":"2022","unstructured":"Kattih B et al (2022) Clinical outcomes of subcutaneous vs. transvenous implantable defibrillator therapy in a polymorbid patient cohort. Front Cardiovasc Med 9:1008311. https:\/\/doi.org\/10.3389\/fcvm.2022.1008311","journal-title":"Front Cardiovasc Med"},{"issue":"6","key":"1121_CR7","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.3390\/jcm14062058","volume":"14","author":"J Simpson","year":"2025","unstructured":"Simpson J et al (2025) Long-Term Complications Related to Cardiac Implantable Electronic Devices. J Clin Med 14(6):2058. https:\/\/doi.org\/10.3390\/jcm14062058","journal-title":"J Clin Med"},{"issue":"19","key":"1121_CR8","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1161\/CIRCULATIONAHA.106.663807","volume":"115","author":"T Kleemann","year":"2007","unstructured":"Kleemann T et al (2007) Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years. Circulation 115(19):2474\u20132480. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.663807","journal-title":"Circulation"},{"key":"1121_CR9","doi-asserted-by":"publisher","first-page":"1397138","DOI":"10.3389\/fcvm.2024.1397138","volume":"11","author":"F Schiedat","year":"2024","unstructured":"Schiedat F et al (2024) Comparison of infection and complication rates associated with transvenous vs. subcutaneous defibrillators in patients with stage 4 chronic kidney disease: a\u00a0multicenter long-term retrospective follow-up. Front Cardiovasc Med 11:1397138. https:\/\/doi.org\/10.3389\/fcvm.2024.1397138","journal-title":"Front Cardiovasc Med"},{"issue":"3","key":"1121_CR10","doi-asserted-by":"publisher","first-page":"222","DOI":"10.11909\/j.issn.1671-5411.2018.03.004","volume":"15","author":"SB Westerman","year":"2018","unstructured":"Westerman SB, El-Chami M (2018) The subcutaneous implantable cardioverter defibrillator--review of the recent data. J Geriatr Cardiol 15(3):222\u2013228. https:\/\/doi.org\/10.11909\/j.issn.1671-5411.2018.03.004","journal-title":"J Geriatr Cardiol"},{"issue":"11","key":"1121_CR11","doi-asserted-by":"publisher","first-page":"3417","DOI":"10.19102\/icrm.2018.091104","volume":"9","author":"NS Zeineh","year":"2018","unstructured":"Zeineh NS, Prutkin JM (2018) The Subcutaneous Implantable Cardioverter-defibrillator: New Features and Implant Techniques and Future Developments. J Innov Card Rhythm Manag 9(11):3417\u20133424. https:\/\/doi.org\/10.19102\/icrm.2018.091104","journal-title":"J Innov Card Rhythm Manag"},{"issue":"3","key":"1121_CR12","first-page":"e004660","volume":"10","author":"AK Gehi","year":"2017","unstructured":"Gehi\u00a0AK et\u00a0al (2017) Current status of subcutaneous ICD therapy. Circ Arrhythmia Electrophysiol 10(3):e4660","journal-title":"Circ Arrhythmia Electrophysiol"},{"issue":"2","key":"1121_CR13","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1002\/ehf2.14249","volume":"10","author":"S Wolf","year":"2023","unstructured":"Wolf S, G\u00f6tz G, Wernly B, Wild C (2023) Subcutaneous implantable cardioverter-defibrillator: a systematic review of comparative effectiveness and safety. ESC Heart Fail 10(2):808\u2013823. https:\/\/doi.org\/10.1002\/ehf2.14249","journal-title":"ESC Heart Fail"},{"issue":"21","key":"1121_CR14","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1093\/eurheartj\/ehab921","volume":"43","author":"PD Lambiase","year":"2022","unstructured":"Lambiase PD et al (2022) Subcutaneous implantable cardioverter-defibrillators: long-term results of the EFFORTLESS study. Eur Heart J 43(21):2037\u20132050. https:\/\/doi.org\/10.1093\/eurheartj\/ehab921","journal-title":"Eur Heart J"},{"issue":"9","key":"1121_CR15","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1161\/CIRCULATIONAHA.113.003042","volume":"128","author":"R Weiss","year":"2013","unstructured":"Weiss R et al (2013) Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator. Circulation 128(9):944\u2013953. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.113.003042","journal-title":"Circulation"},{"key":"1121_CR16","unstructured":"Medtronic AuroraTM EV-ICD Manual. https:\/\/manuals.medtronic.com\/manuals\/"},{"key":"1121_CR17","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.124.071795","author":"P Friedman","year":"2024","unstructured":"Friedman\u00a0P, Murgatroyd\u00a0F, Boersma\u00a0LVA et\u00a0al (2024) Performance and safety of the extravascular Implantable cardioverter-defibrillator through long-term follow-up: final results from the pivotal study. Circulation. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.124.071795","journal-title":"Circulation"},{"issue":"8","key":"1121_CR18","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1016\/j.jacep.2024.02.033","volume":"10","author":"C Swerdlow","year":"2024","unstructured":"Swerdlow\u00a0C, Gillberg\u00a0J, Boersma\u00a0LVA, Manlucu\u00a0J, Zhang\u00a0X, Zhang\u00a0Y, Hernandez\u00a0AA, Bhatia\u00a0V, Murgatroyd\u00a0F (2024) Extravascular implantable cardioverter-defibrillator sensing and detection in a\u00a0large global population. JACC Clin Electrophysiol 10(8):1896\u20131912. https:\/\/doi.org\/10.1016\/j.jacep.2024.02.033","journal-title":"JACC Clin Electrophysiol"},{"issue":"8","key":"1121_CR19","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.jacep.2016.12.026","volume":"3","author":"JYS Chan","year":"2017","unstructured":"Chan\u00a0JYS, Lelakowski\u00a0J, Murgatroyd\u00a0FD, Boersma\u00a0LV, Cao\u00a0J, Nikolski\u00a0V, Wouters\u00a0G, Hall\u00a0MCS (2017) Novel extravascular defibrillation configuration with a\u00a0coil in the substernal space: the ASD clinical study. JACC Clin Electrophysiol 3(8):905\u2013910. https:\/\/doi.org\/10.1016\/j.jacep.2016.12.026","journal-title":"JACC Clin Electrophysiol"},{"key":"1121_CR20","doi-asserted-by":"publisher","unstructured":"Crozier I et\u00a0al Periprocedural outcomes from the postmarket study of the extravascular implantable cardioveret-defibrillator: preliminary Enlighten study results and meta analysis. https:\/\/doi.org\/10.1016\/j.hrthm.2025.02.012","DOI":"10.1016\/j.hrthm.2025.02.012"},{"issue":"2","key":"1121_CR21","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.jacep.2018.11.003","volume":"5","author":"LVA Boersma","year":"2019","unstructured":"Boersma\u00a0LVA, Merkely\u00a0B, Neuzil\u00a0P, Crozier\u00a0IG, Akula\u00a0DN, Timmers\u00a0L et\u00a0al (2019) Therapy from a\u00a0novel substernal lead: the ASD2 study. JACC Clin Electrophysiol 5(2):186\u2013196. https:\/\/doi.org\/10.1016\/j.jacep.2018.11.003","journal-title":"JACC Clin Electrophysiol"},{"issue":"1","key":"1121_CR22","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.hroo.2024.09.022","volume":"6","author":"LVA Boersma","year":"2024","unstructured":"Boersma LVA, Amin A, Cl\u00e9menty N, Duncker D, Engel G, Epstein L, Kuriachan V, Frazier-Mills C, Gwechenberger M, Nishii N, Lande J, Wiggenhorn C, Crozier I (2024) Design of a post-market registry for the extravascular implantable cardioverter-defibrillator: The Enlighten Study. Heart Rhythm 6(1):64\u201369. https:\/\/doi.org\/10.1016\/j.hroo.2024.09.022","journal-title":"Heart Rhythm"},{"issue":"10","key":"1121_CR23","doi-asserted-by":"publisher","first-page":"euad301","DOI":"10.1093\/europace\/euad301","volume":"25","author":"I Crozier","year":"2023","unstructured":"Crozier\u00a0I, Haqqani\u00a0H, Kotschet\u00a0E, Wiggenhorn\u00a0C, Lande\u00a0J, Thompson\u00a0A, Cheng\u00a0A, Bhatia\u00a0V, O\u2019Donnell\u00a0D (2023) Three-year chronic follow-up from the pilot study of a\u00a0substernal extravascular implantable cardioverter-defibrillator. Europace 25(10):euad301. https:\/\/doi.org\/10.1093\/europace\/euad301","journal-title":"Europace"},{"issue":"4","key":"1121_CR24","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.hrthm.2017.11.030","volume":"15","author":"DP Sholevar","year":"2018","unstructured":"Sholevar DP et al (2018) Feasibility of extravascular pacing with a novel substernal electrode configuration: the Substernal Pacing Acute Clinical Evaluation study. Heart Rhythm 15(4):536\u2013542. https:\/\/doi.org\/10.1016\/j.hrthm.2017.11.030","journal-title":"Heart Rhythm"},{"issue":"1","key":"1121_CR25","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.hroo.2024.09.022","volume":"6","author":"LVA Boersma","year":"2025","unstructured":"Boersma LVA et\u00a0al (2025) Design of a\u00a0post market registry for the extravascular implantable cardioverter-defibrillator: the Enlighten Study. Heart Rhythm 6(1):64\u201369. https:\/\/doi.org\/10.1016\/j.hroo.2024.09.022","journal-title":"Heart Rhythm"}],"container-title":["Herzschrittmachertherapie + Elektrophysiologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00399-025-01121-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00399-025-01121-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00399-025-01121-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T17:06:56Z","timestamp":1782925616000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00399-025-01121-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,11]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1121"],"URL":"https:\/\/doi.org\/10.1007\/s00399-025-01121-6","relation":{},"ISSN":["0938-7412","1435-1544"],"issn-type":[{"value":"0938-7412","type":"print"},{"value":"1435-1544","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,11]]},"assertion":[{"value":"24 October 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"C.\u00a0Shepley, S.\u00a0Allen, and V.\u00a0Andersen are employees of Medtronic Inc.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}